1. Home
  2. CINGW vs KTF Comparison

CINGW vs KTF Comparison

Compare CINGW & KTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CINGW
  • KTF
  • Stock Information
  • Founded
  • CINGW N/A
  • KTF 1988
  • Country
  • CINGW United States
  • KTF United States
  • Employees
  • CINGW 13
  • KTF N/A
  • Industry
  • CINGW Biotechnology: Pharmaceutical Preparations
  • KTF Finance Companies
  • Sector
  • CINGW Health Care
  • KTF Finance
  • Exchange
  • CINGW Nasdaq
  • KTF Nasdaq
  • Market Cap
  • CINGW N/A
  • KTF N/A
  • IPO Year
  • CINGW 2021
  • KTF N/A
  • Fundamental
  • Price
  • CINGW $0.06
  • KTF $9.99
  • Analyst Decision
  • CINGW
  • KTF
  • Analyst Count
  • CINGW 0
  • KTF 0
  • Target Price
  • CINGW N/A
  • KTF N/A
  • AVG Volume (30 Days)
  • CINGW N/A
  • KTF 103.3K
  • Earning Date
  • CINGW N/A
  • KTF 01-01-0001
  • Dividend Yield
  • CINGW N/A
  • KTF 3.54%
  • EPS Growth
  • CINGW N/A
  • KTF N/A
  • EPS
  • CINGW N/A
  • KTF 0.39
  • Revenue
  • CINGW N/A
  • KTF N/A
  • Revenue This Year
  • CINGW N/A
  • KTF N/A
  • Revenue Next Year
  • CINGW N/A
  • KTF N/A
  • P/E Ratio
  • CINGW N/A
  • KTF $23.10
  • Revenue Growth
  • CINGW N/A
  • KTF N/A
  • 52 Week Low
  • CINGW N/A
  • KTF $7.40
  • 52 Week High
  • CINGW N/A
  • KTF $9.12
  • Technical
  • Relative Strength Index (RSI)
  • CINGW N/A
  • KTF 60.85
  • Support Level
  • CINGW N/A
  • KTF $9.95
  • Resistance Level
  • CINGW N/A
  • KTF $10.04
  • Average True Range (ATR)
  • CINGW 0.00
  • KTF 0.07
  • MACD
  • CINGW 0.00
  • KTF -0.00
  • Stochastic Oscillator
  • CINGW 0.00
  • KTF 61.54

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Share on Social Networks: